Table 3.

Patients outcomes.

	Hyperuricemia(n =72)	Normuricemia(n =177)	P-value
MACE	23 (31.9)	29 (16.3)	0.006
Cardiovascular death	5 (6.9)	9 (5.1)	0.554
Nonfatal MI	1 (1.4)	1 (0.5)	0.496
Heart failure	1 (1.4)	2 (1.1)	1.000
Stroke	2 (2.8)	1 (0.5)	0.201
Angina rehospitalization	14 (19.4)	16 (9.0)	0.022

MACE, major adverse cardiovascular events; MI, myocardial infarction.